Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Workflow, By Type, By Scale, By Region and Competition, 2020-2030F

Description

Global Automated And Closed Cell Therapy Processing Systems Market has valued at USD 931.08 Million in 2024 and is expected to reach USD 1597.30 Million by 2030 with a CAGR of 9.37% during the forecast period. The increasing appeal of regenerative medicine and cell therapies, along with the numerous advantages associated with automation technologies in their development, is projected to drive market expansion. Moreover, the increasing incorporation of software technologies into advanced therapy development procedures is also expected to stimulate market growth. Additionally, the rising investments made by biopharmaceutical manufacturers in the development of cellular therapy products, supported by multiple rounds of funding, are poised to provide attractive growth prospects for the market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 931.08 Million
Market Size 2030	USD 1597.30 Million
CAGR 2025-2030	9.37%
Fastest Growing Segment	Expansion
Largest Market	North America

Key Market Drivers

Growing Popularity of Regenerative Medicine and Cell Therapies

Regenerative medicine and cell therapies represent a groundbreaking frontier in modern healthcare, offering new hope for treating a variety of challenging medical conditions. As these therapies gain momentum and continue to demonstrate their effectiveness, they are poised to significantly impact the healthcare industry. One crucial factor enabling the scalability and efficiency of regenerative medicine and cell therapy production is the adoption of automated and closed cell therapy processing systems.

The increasing popularity of regenerative medicine and cell therapies has led to a surge in demand for these groundbreaking treatments. However, with greater demand comes the need for efficient, scalable, and consistent manufacturing processes. Automated and closed cell therapy processing systems offer a solution to this challenge. They can handle large-scale production while maintaining precise control over cell culture conditions. This scalability is essential to meet the growing global demand for these therapies. In June 2024, Cryoport Systems, LLC joined forces with Minaris Regenerative Medicine to advance the development of cell and gene therapies. This partnership is centered on offering integrated solutions for the storage, transportation, and processing of cell and gene-based products. The collaboration aims to facilitate the commercialization and clinical trials of regenerative therapies.

Key Market Challenges

High Initial Costs

One of the most significant barriers to the adoption of automated cell therapy processing systems is the high initial cost associated with acquiring and implementing these advanced technologies. The investment required to purchase, install, and configure such systems can be substantial, often running into the millions of dollars. This poses a particular challenge for smaller biotech companies and research institutions that may lack the financial resources to make such large investments. Additionally, the long-term return on investment (ROI) may not be immediately clear, leading to hesitation among potential stakeholders. The financial strain associated with these initial costs can deter many from entering the market or adopting these systems, despite the potential long-term benefits in terms of efficiency, scalability, and precision.

Key Market Trends

Increasing Adoption of Automated Systems for Efficiency and Consistency

The demand for automated cell therapy processing systems is rising globally due to the need for increased efficiency and consistency in manufacturing processes. Cell therapy, which includes innovative treatments such as stem cell and gene therapies, has complex production requirements that necessitate precise control over various parameters, including temperature, oxygen levels, and pH. Traditionally, manual processing could result in variability and human error, which compromises product quality and consistency. Automated systems are designed to standardize processes and reduce errors, ensuring more reliable outcomes.

Key Market Players

Miltenyi Biotec B.V. & Co. KG
Lonza Group AG
Fresenius Kabi AG
Global Life Sciences Solutions USA LLC
BioSpherix, LLC
Terumo Corp
Sartorius AG
ThermoGenesis Holdings Inc
Cellares Corporation
Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Automated And Closed Cell Therapy Processing Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated And Closed Cell Therapy Processing Systems Market, By Workflow:

Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others

Automated And Closed Cell Therapy Processing Systems Market, By Type:

Stem Cell Therapy
Non-Stem Cell Therapy

Automated And Closed Cell Therapy Processing Systems Market, By Scale:

Pre-commercial/ R&D Scale
Commercial Scale

Automated And Closed Cell Therapy Processing Systems Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated And Closed Cell Therapy Processing Systems Market.

Available Customizations:

Global Automated And Closed Cell Therapy Processing Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated And Closed Cell Therapy Processing Systems Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others)
- 5.2.2. By Type (Stem Cell Therapy, Non-Stem Cell Therapy)
- 5.2.3. By Scale (Pre-commercial/ R&D Scale, Commercial Scale)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Automated And Closed Cell Therapy Processing Systems Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Workflow
- 6.2.2. By Type
- 6.2.3. By Scale
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Workflow
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By Scale
- 6.3.2. Canada Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Workflow
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By Scale
- 6.3.3. Mexico Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Workflow
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By Scale

7. Europe Automated And Closed Cell Therapy Processing Systems Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Workflow
- 7.2.2. By Type
- 7.2.3. By Scale
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Workflow
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Scale
- 7.3.2. United Kingdom Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Workflow
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Scale
- 7.3.3. Italy Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Workflow
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Scale
- 7.3.4. France Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Workflow
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By Scale
- 7.3.5. Spain Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Workflow
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By Scale

8. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Workflow
- 8.2.2. By Type
- 8.2.3. By Scale
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Workflow
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Scale
- 8.3.2. India Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Workflow
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Scale
- 8.3.3. Japan Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Workflow
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Scale
- 8.3.4. South Korea Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Workflow
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By Scale
- 8.3.5. Australia Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Workflow
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By Scale

9. South America Automated And Closed Cell Therapy Processing Systems Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Workflow
- 9.2.2. By Type
- 9.2.3. By Scale
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Workflow
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Scale
- 9.3.2. Argentina Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Workflow
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Scale
- 9.3.3. Colombia Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Workflow
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Scale

10. Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Workflow
- 10.2.2. By Type
- 10.2.3. By Scale
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Workflow
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By Scale
- 10.3.2. Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Workflow
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By Scale
- 10.3.3. UAE Automated And Closed Cell Therapy Processing Systems Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Workflow
    - 10.3.3.2.2. By Type
    - 10.3.3.2.3. By Scale

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Miltenyi Biotec B.V. & Co. KG
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Lonza Group AG
14.3. Fresenius Kabi AG
14.4. Global Life Sciences Solutions USA LLC
14.5. BioSpherix, LLC
14.6. Terumo Corp
14.7. Sartorius AG
14.8. ThermoGenesis Holdings Inc
14.9. Cellares Corporation
14.10. Thermo Fisher Scientific Inc